bpc-157 human clinical trials evidence review safety Here's a nice graphic on that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D bpc-157 human clinical trials evidence
Description
Absorption of isotopically labelled 5-formyl-THF across the colon at a considerably lower rate (about one-fiftieth) than across the small intestine has been reported
How Does BPC-157 Compare to Traditional Treatments
Once SAMe has given up its methyl group, it is converted to S-Adenosyl-Homocysteine (SAH)
Doses are total blend
doi: 10.7863/jum.1997.16.8.549
LiveWell Peptides makes no medical claims
